Evaluating the effect of tumor size and sidedness on prognosis in stage 2 colon cancer: a retrospective population study

被引:0
作者
Demir, H. [1 ]
Caglayan, D. [2 ]
Kaman, O. [3 ]
Inanc, M. [4 ]
Urvay, S. [5 ]
Beypinar, I [6 ]
Demirci, A. [7 ]
Davarci, S. E. [1 ]
Araz, M. [2 ]
Baykara, M. [1 ]
Artac, M. [2 ]
Yildiz, F. [3 ]
机构
[1] Afyonkarahisar Hlth Sci Univ, Dept Internal Med & Med Oncol, Sch Med, Afyon, Turkey
[2] Necmettin Erbakan Univ, Dept Internal Med & Med Oncol, Sch Med, Konya, Turkey
[3] Abdurrahman Yurtaslan Ankara Oncol Training & Res, Dept Internal Med & Med Oncol, Ankara, Turkey
[4] Erciyes Univ, Fac Med, Dept Internal Med & Med Oncol, Kayseri, Turkey
[5] Acibadem Univ, Dept Radiotherapy, Vocat Sch Hlth Serv, Istanbul, Turkey
[6] Eskisehir City Hosp, Dept Internal Med & Med Oncol, Eskisehir, Turkey
[7] Sakarya Univ Training & Res Hosp, Dept Med Oncol, Sakarya, Turkey
关键词
Colon cancer; Tumor size; Tumor sidedness; Prognosis; ADJUVANT CHEMOTHERAPY; COLORECTAL-CANCER; SURVIVAL; SURVEILLANCE;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
OBJECTIVE: In this study. we aimed to evaluate the effect of tumor size and tumor sidedness on prognosis in patients with stage 2 colon cancer. PATIENTS AND METHODS: Data of 501 patients diagnosed with stage 2 colon cancer were evaluated retrospectively. It was evaluated whether the patients' age, gender, tumor differentiation, tumor node metastasis (TNM) stage, overall survival rate, and disease-free survival rate had any correlation with horizontal tumor diameter and tumor sidedness. In the ROC analysis performed to determine the cut-off value for the tumor diameter, which we think will predict survival, no significant results were obtained with maximum sensitivity and specificity. Therefore, the median value of the tumor diameter, which is 5 cm, was accepted as the cut-off value. Kaplan-Meier method and Cox regression analysis were used for survival analysis and determination of prognostic factors. RESULTS: When the patients were evaluated in terms of tumor localization, 189 (37.7%) patients had right colon tumors and 312 (62.3%) patients had left colon tumors. There was no statistically significant difference in terms of disease-free survival and overall survival according to tumor localization. When the patients were analyzed by dividing them into two groups according to the horizontal tumor size (<5 cm and >= 5 cm), no statistically significant difference was found between the groups in terms of disease-free survival (DFS) and overall survival (OS) p=0.085, p=0.699, respectively. CONCLUSIONS: Our results suggest that the management of patients with stage 2 colon cancer requires a better understanding of tumor biology rather than features such as tumor size and localization.
引用
收藏
页码:1328 / 1340
页数:13
相关论文
共 50 条
  • [41] Analysis of tumor microenvironmental features to refine prognosis by T, N risk group in patients with stage III colon cancer (NCCTG N0147) (Alliance)
    Lee, H.
    Sha, D.
    Foster, N. R.
    Shi, Q.
    Alberts, S. R.
    Smyrk, T. C.
    Sinicrope, F. A.
    ANNALS OF ONCOLOGY, 2020, 31 (04) : 487 - 494
  • [42] Prognostic Value of the Tumor Size in Resectable Colorectal Cancer with Different Primary Locations: A Retrospective Study with the Propensity Score Matching
    Li, Xiao
    An, Bang
    Ma, Jincai
    He, Bo
    Qi, Jianni
    Wang, Wenwen
    Qin, Chengyong
    Zhao, Qi
    JOURNAL OF CANCER, 2019, 10 (02): : 313 - 322
  • [43] The prognostic value of tumor budding in a thoroughly characterized stage II colon cancer population in the context of a national screening program
    Kristensen, Maria Pihlmann
    Korsgaard, Ulrik
    Timm, Signe
    Hansen, Torben Frostrup
    Zlobec, Inti
    Hager, Henrik
    Kjaer-Frifeldt, Sanne
    HUMAN PATHOLOGY, 2024, 146 : 15 - 22
  • [44] Prognostic impact of tumor location in stage IV colon cancer: A propensity score analysis in a multicenter study
    Ishihara, Soichiro
    Nishikawa, Takeshi
    Tanaka, Toshiaki
    Tanaka, Junichiro
    Kiyomatsu, Tomomichi
    Kawai, Kazushige
    Hata, Keisuke
    Nozawa, Hioaki
    Kanazawa, Takamitsu
    Kazama, Shinsuke
    Yamaguchi, Hironori
    Sunami, Eiji
    Kitayama, Joji
    Hashiguchi, Yojiro
    Sugihara, Kenichi
    Watanabe, Toshiaki
    INTERNATIONAL JOURNAL OF SURGERY, 2014, 12 (09) : 925 - 930
  • [45] Neoadjuvant Therapy in Stage II/III Rectal Cancer: A Retrospective Study in a Disparate Population and the Effect on Survival
    Gan, Tong
    Chen, Quan
    Huerta, Carlos T.
    Huang, Bin
    Evers, B. Mark
    Patel, Jitesh A.
    DISEASES OF THE COLON & RECTUM, 2021, 64 (10) : 1212 - 1221
  • [46] Circulating tumor DNA guided adjuvant chemotherapy in stage II colon cancer (MEDOCC-CrEATE): study protocol for a trial within a cohort study
    Schraa, S. J.
    van Rooijen, K. L.
    van der Kruijssen, D. E. W.
    Alarcon, C. Rubio
    Phallen, J.
    Sausen, M.
    Simmons, J.
    Coupe, V. M. H.
    van Grevenstein, W. M. U.
    Elias, S.
    Verkooijen, H. M.
    Lacle, M. M.
    Bosch, L. J. W.
    van den Broek, D.
    Meijer, G. A.
    Velculescu, V. E.
    Fijneman, R. J. A.
    Vink, G. R.
    Koopman, M.
    BMC CANCER, 2020, 20 (01)
  • [47] The prognostic importance of miR-21 in stage II colon cancer: a population-based study
    Kjaer-Frifeldt, S.
    Hansen, T. F.
    Nielsen, B. S.
    Joergensen, S.
    Lindebjerg, J.
    Soerensen, F. B.
    Christensen, R. dePont
    Jakobsen, A.
    BRITISH JOURNAL OF CANCER, 2012, 107 (07) : 1169 - 1174
  • [48] Impact of the Number of Histologically Examined Lymph Nodes on Prognosis in Colon Cancer: A Population-Based Study in The Netherlands
    Kelder, Wendy
    Inberg, Bas
    Schaapveld, Michael
    Karrenbeld, Arend
    Grond, Joris
    Wiggers, Theo
    Plukker, John T.
    DISEASES OF THE COLON & RECTUM, 2009, 52 (02) : 260 - 267
  • [49] Screening mammography use and chemotherapy among female stage II colon cancer patients: a retrospective cohort study
    Yu, Xinhua
    McBean, Alexander M.
    BMC HEALTH SERVICES RESEARCH, 2010, 10
  • [50] Effect of sidedness on survival among patients with early-stage colon cancer: a SEER-based propensity score matching analysis
    Huang, Zhuang-Sheng
    Wu, Jun-Wei
    Li, Ying
    Lin, Yu-Hai
    Li, Xu-Yuan
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2021, 19 (01)